Protagenic Therapeutics, Inc.
PTIX
$1.80
-$0.10-5.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.72M | 4.10M | -- | ||
| Total Receivables | 44.00K | 98.60K | -- | ||
| Inventory | 1.10K | 1.10K | -- | ||
| Prepaid Expenses | 90.60K | 135.10K | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 2.86M | 4.33M | -- | ||
|
|
|||||
| Total Current Assets | 2.86M | 4.33M | -- | ||
| Net Property, Plant & Equipment | 51.40K | 64.00K | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 2.09M | 2.09M | -- | ||
| Total Assets | 5.00M | 6.49M | -- | ||
|
|
|||||
| Total Accounts Payable | 1.64M | 2.08M | -- | ||
| Total Accrued Expenses | 408.00K | 505.80K | -- | ||
| Short-term Debt | 4.00M | 4.01M | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | 3.66M | 3.86M | -- | ||
| Total Other Current Liabilities | 3.66M | 3.86M | -- | ||
| Total Current Liabilities | 9.70M | 10.46M | -- | ||
|
|
|||||
| Total Current Liabilities | 9.70M | 10.46M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 4.00M | 4.01M | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 9.70M | 10.46M | -- | ||
|
|
|||||
| Common Stock & APIC | 6.85M | 6.74M | -- | ||
| Retained Earnings | -11.32M | -10.46M | -- | ||
| Treasury Stock & Other | -221.20K | -258.20K | -- | ||
| Total Common Equity | -4.70M | -3.97M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 0.00 | 0.00 | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 0.00 | 0.00 | -- | ||
|
|
|||||
| Total Common Equity | -4.70M | -3.97M | -- | ||
| Total Preferred Equity | 0.00 | 0.00 | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -4.70M | -3.97M | -- | ||
|
|
|||||